Published in J Gen Virol on October 01, 1996
Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol (2011) 2.86
Effects of targeting herpes simplex virus type 1 gD to the endoplasmic reticulum and trans-Golgi network. J Virol (1999) 2.10
Herpes virus fusion and entry: a story with many characters. Viruses (2012) 2.05
Site-directed and linker insertion mutagenesis of herpes simplex virus type 1 glycoprotein H. J Virol (1997) 1.88
The amino terminus of Epstein-Barr virus glycoprotein gH is important for fusion with epithelial and B cells. J Virol (2005) 1.70
Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans. J Virol (2008) 1.64
The transmembrane domain and cytoplasmic tail of herpes simplex virus type 1 glycoprotein H play a role in membrane fusion. J Virol (2002) 1.39
N-terminal mutants of herpes simplex virus type 2 gH are transported without gL but require gL for function. J Virol (2007) 1.14
Structural basis for the physiological temperature dependence of the association of VP16 with the cytoplasmic tail of herpes simplex virus glycoprotein H. J Virol (2005) 1.00
Insertion mutations in herpes simplex virus 1 glycoprotein H reduce cell surface expression, slow the rate of cell fusion, or abrogate functions in cell fusion and viral entry. J Virol (2009) 0.98
Reevaluating herpes simplex virus hemifusion. J Virol (2010) 0.95
The cytoplasmic domain of varicella-zoster virus glycoprotein H regulates syncytia formation and skin pathogenesis. PLoS Pathog (2014) 0.88
Mutations in the cytoplasmic tail of herpes simplex virus 1 gH reduce the fusogenicity of gB in transfected cells. J Virol (2013) 0.88
A soluble form of Epstein-Barr virus gH/gL inhibits EBV-induced membrane fusion and does not function in fusion. Virology (2012) 0.86
Interplay between the Herpes Simplex Virus 1 gB Cytodomain and the gH Cytotail during Cell-Cell Fusion. J Virol (2015) 0.84
A Functional Interaction between Herpes Simplex Virus 1 Glycoprotein gH/gL Domains I and II and gD Is Defined by Using Alphaherpesvirus gH and gL Chimeras. J Virol (2015) 0.82
Herpesvirus gB: A Finely Tuned Fusion Machine. Viruses (2015) 0.80
A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J Virol (1992) 4.12
Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J (1986) 3.89
An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization. J Gen Virol (1986) 3.63
Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans. J Virol (1986) 3.36
Cloning and molecular characterization of the murine herpesvirus 68 genome. J Gen Virol (1990) 3.33
Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer (1989) 3.30
Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity. J Gen Virol (1988) 3.11
The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol (1992) 3.09
The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J Gen Virol (1989) 2.40
Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. J Gen Virol (1992) 2.38
Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J Virol (1984) 2.36
A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med (2000) 2.09
Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it. J Virol (1986) 2.07
Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutants. J Virol (1988) 1.74
Introduction of the herpes simplex virus thymidine kinase gene into mouse cells using virus DNA or transformed cell DNA. Cell (1978) 1.69
Mutations in the cytoplasmic tail of herpes simplex virus glycoprotein H suppress cell fusion by a syncytial strain. J Virol (1994) 1.64
Antigenic properties and cellular localization of herpes simplex virus glycoprotein H synthesized in a mammalian cell expression system. J Virol (1989) 1.59
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J Clin Pathol (1990) 1.57
Diagnosis of human parvovirus infection by dot-blot hybridization using cloned viral DNA. J Med Virol (1985) 1.55
Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein H. J Virol (1991) 1.44
Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. J Infect Dis (1994) 1.31
Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus. J Gen Virol (1991) 1.15
The herpes simplex virus type 1 Fc receptor discriminates between IgG1 allotypes. Eur J Immunol (2000) 1.12
Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted. J Virol (1994) 1.11
The detection of virus DNA sequences in a herpes type 2 transformed hamster cell line (333-8-9). Int J Cancer (1976) 0.99
Methionine regulatory defects in Salmonella typhimurium arising from amber-suppressible mutations. J Gen Microbiol (1972) 0.96
Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology (1990) 0.94
Purification of a trifunctional enzyme, catalysing three steps of the histidine pathway, from Neurospora crassa. Biochem J (1969) 0.93
The use of monoclonal antibodies in (reverse) passive haemagglutination tests for herpes simplex virus antigens and antibodies. J Med Virol (1983) 0.92
A study of primary neuronal infection by mutants of herpes simplex virus type 1 lacking dispensable and non-dispensable glycoproteins. J Gen Virol (1999) 0.92
In vivo complementation studies of a glycoprotein H-deleted herpes simplex virus-based vector. J Gen Virol (1996) 0.91
Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant. J Gen Virol (1988) 0.90
The herpes simplex virus type 2 equivalent of the herpes simplex virus type 1 US7 gene and its flanking sequences. Virology (1986) 0.89
Synthesis of plant virus coat proteins in an animal cell-free system. Nat New Biol (1973) 0.83
Conservation of HPV-16 E6/E7 ORF sequences in a cervical carcinoma. J Med Virol (1992) 0.80
The state of the herpes genome. Nature (1983) 0.79
Osteopontin is not a marker for proliferating human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1995) 0.77
Properties of cells carrying the herpes simplex virus type 2 thymidine kinase gene: mechanisms of reversion to a thymidine kinase-negative phenotype. J Virol (1980) 0.77
Virus-specific DNA sequences present in cells which carry the herpes simplex virus thymidine kinase gene. J Gen Virol (1979) 0.77
Herpes virus-based vectors. Br Med Bull (1995) 0.76
The structure of tobacco rattle virus ribonucleic acids: nature of the 3'-terminal nucleosides. J Gen Virol (1972) 0.75
Incorporation of the herpes simplex virus thymidine-kinase gene into a mammalian cell line using fragments of the virus genome. IARC Sci Publ (1978) 0.75
High expression of osteopontin mRNA in human macrophages but not human vascular smooth muscle cells in culture. Ann N Y Acad Sci (1995) 0.75
Hybridization techniques. Lab Res Methods Biol Med (1982) 0.75